HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuhiko Moriyama Selected Research

Fibrosis (Cirrhosis)

7/2022COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report.
11/2021Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan.
7/2021Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.
7/2018Apoptosis and non-alcoholic fatty liver diseases.
7/2014Improvement in the nutritional status and clinical conditions of patients with liver failure using a liver diet combined with a branched chain amino acids-enriched elemental diet.
6/2006Treatment of interferon-alpha for chronic hepatitis C.
8/2002SEN virus infection does not affect the progression of non-A to -E liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuhiko Moriyama Research Topics

Disease

35Hepatocellular Carcinoma (Hepatoma)
03/2024 - 04/2002
34Infections
06/2023 - 12/2006
25Chronic Hepatitis C
03/2024 - 11/2002
22Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 01/2003
19Neoplasms (Cancer)
03/2024 - 12/2002
18Liver Diseases (Liver Disease)
05/2022 - 11/2001
11Chronic Hepatitis (Chronic Active Hepatitis)
11/2021 - 08/2002
9Hepatitis
05/2022 - 08/2002
7Fibrosis (Cirrhosis)
07/2022 - 08/2002
6Hepatitis C
01/2009 - 06/2002
5Acute Liver Failure (Fulminant Hepatic Failure)
06/2023 - 01/2013
5Stomach Neoplasms (Stomach Cancer)
02/2022 - 10/2008
5Hepatitis B
10/2019 - 01/2003
4Carcinogenesis
03/2024 - 12/2002
4Liver Failure
06/2021 - 01/2003
4Chronic Hepatitis B
02/2010 - 01/2003
3Inflammation (Inflammations)
04/2020 - 09/2004
3Autoimmune Hepatitis
02/2018 - 01/2004
2Stroke (Strokes)
02/2023 - 05/2018
2Pathologic Constriction (Stenosis)
10/2022 - 05/2018
2Pancreatitis
10/2022 - 10/2017
2Esophageal and Gastric Varices (Esophageal Varices)
01/2022 - 11/2014
2Adenocarcinoma
12/2021 - 08/2020
2Ascites
07/2021 - 07/2014
2Alcoholism (Alcohol Abuse)
03/2021 - 10/2019
2Obesity
03/2021 - 01/2019
2Neoplasm Metastasis (Metastasis)
09/2020 - 10/2008
2Ulcerative Colitis
09/2020 - 05/2010
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2020 - 04/2020
2Coinfection
11/2019 - 11/2001
2Persistent Infection
10/2019 - 02/2007
2Non-alcoholic Fatty Liver Disease
01/2019 - 07/2018
2Hepatic Encephalopathy
07/2018 - 07/2014
2Exanthema (Rash)
06/2018 - 01/2016
2Alcoholic Fatty Liver
05/2018 - 01/2013
2Virus Diseases (Viral Diseases)
01/2018 - 12/2006
2Hemorrhage
02/2016 - 05/2015
2Tuberculosis (Tuberculoses)
01/2016 - 01/2015
2Latent Tuberculosis
01/2016 - 01/2015
2Autoimmune Diseases (Autoimmune Disease)
01/2016 - 01/2004
2Disease Progression
01/2013 - 12/2006
1Liver Neoplasms (Liver Cancer)
09/2023
1Acute-On-Chronic Liver Failure
06/2023

Drug/Important Bio-Agent (IBA)

21InterferonsIBA
07/2022 - 01/2003
18Antiviral Agents (Antivirals)IBA
07/2022 - 12/2002
10RNA (Ribonucleic Acid)IBA
08/2020 - 11/2001
9Proteins (Proteins, Gene)FDA Link
05/2022 - 09/2004
9DNA (Deoxyribonucleic Acid)IBA
01/2020 - 08/2002
6ZincIBA
07/2021 - 11/2006
5CytokinesIBA
03/2024 - 01/2017
5Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2019 - 06/2002
4VaccinesIBA
01/2021 - 01/2018
4Biomarkers (Surrogate Marker)IBA
07/2020 - 02/2007
4Ribavirin (Virazole)FDA LinkGeneric
01/2016 - 06/2006
3Messenger RNA (mRNA)IBA
03/2024 - 05/2018
3ChromatinIBA
03/2024 - 09/2023
3Hepatitis A AntibodiesIBA
06/2023 - 12/2020
3Subgenomic RNAIBA
05/2022 - 01/2022
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2022 - 12/2002
3Immune Checkpoint InhibitorsIBA
12/2021 - 09/2020
3Toll-Like Receptors (Toll-Like Receptor)IBA
07/2021 - 05/2020
3SteroidsIBA
06/2021 - 01/2004
3entecavirFDA Link
02/2010 - 09/2008
3Interferon-alpha (Interferon Alfa)IBA
01/2009 - 01/2005
3AntibodiesIBA
02/2007 - 04/2002
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2005 - 08/2002
2lenvatinibIBA
07/2022 - 05/2020
2favipiravirIBA
05/2022 - 02/2022
2NucleotidesIBA
02/2022 - 05/2004
2Bevacizumab (Avastin)FDA Link
12/2021 - 01/2021
2NivolumabIBA
12/2021 - 09/2020
2atezolizumabIBA
12/2021 - 01/2021
2glecaprevir and pibrentasvirIBA
11/2021 - 07/2021
2Alanine Transaminase (SGPT)IBA
11/2021 - 02/2005
2zinc chlorideFDA Link
07/2021 - 11/2020
2Phosphotransferases (Kinase)IBA
05/2020 - 03/2019
2Serum AlbuminIBA
02/2020 - 11/2012
2NucleosidesIBA
10/2019 - 02/2009
2IronIBA
05/2018 - 11/2002
2SofosbuvirIBA
01/2018 - 01/2017
2ledipasvirIBA
01/2018 - 01/2017
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2017 - 05/2014
2miriplatinIBA
07/2016 - 03/2016
2Immunoglobulin G (IgG)IBA
01/2016 - 04/2009
2Amino AcidsFDA Link
11/2012 - 12/2004
2Indicators and Reagents (Reagents)IBA
11/2012 - 08/2002
2Lamivudine (Epivir)FDA Link
02/2010 - 09/2008
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2009 - 01/2006
2Immunoglobulins (Immunoglobulin)IBA
04/2009 - 12/2006
2Fluorouracil (Carac)FDA LinkGeneric
10/2008 - 06/2006
2AntigensIBA
01/2005 - 09/2004
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
09/2023
1masitinibIBA
06/2023

Therapy/Procedure

32Therapeutics
07/2022 - 01/2003
3Catheters
10/2022 - 03/2016
3Drug Therapy (Chemotherapy)
02/2019 - 02/2007
2Aftercare (After-Treatment)
07/2022 - 01/2019
2Liver Transplantation
05/2022 - 02/2016
2Blood Transfusion (Blood Transfusions)
03/2019 - 02/2007
2Retreatment
03/2018 - 01/2018